Phase 2 NASH Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)
NASH
Cascade Pharmaceuticals, Inc120 enrolled8 locationsNCT07198386
Recruiting
Phase 2
Digoxin In NASH (CODIN)
MASH - Metabolic Dysfunction-Associated SteatohepatitisNAFLDNASH
Yale University144 enrolled2 locationsNCT06588699
Recruiting
Phase 2
Study of ADI-PEG 20 Versus Placebo in Subjects With NASH
Nonalcoholic Steatohepatitis (NASH)
Polaris Group60 enrolled10 locationsNCT05842512
Recruiting
Phase 2
HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)
NASH
Tasly Pharmaceutical Group Co., Ltd76 enrolled20 locationsNCT05632861
Recruiting
Phase 2
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
NASH - Nonalcoholic Steatohepatitis
Can-Fite BioPharma114 enrolled24 locationsNCT04697810
Recruiting
Phase 2
A phase 2 clinical study to evaluate the efficacy, safety and tolerability of TransT3-60 vs placebo (a powder administered sublingually) in participants with Non-Alcoholic SteatoHepatitis (NASH)
Liver- Non-Alcoholic SteatoHepatitis (NASH)
Invictus Ops Pty Ltd80 enrolled1 locationACTRN12621001710819